Table II.
MIB-1 indices and mitoses.
| Indices | SM | GM |
|---|---|---|
| MIB-1 index | 25.6±19.1 | 35.0±18.1 |
| Stage I–II | 22.2±17.2 | 21.7±10.4 |
| Stage III–IV | 30.8±21.5 | 40.7±18.1 |
| Normal mitosis | 10.6±15.8 | 27.1±24.7a |
| Stage I–II | 6.5±9.6 | 2.7±2.3 |
| Stage III–IV | 17.1±21.4 | 37.5±22.1b |
| Atypical mitosis | 3.9±7.5 | 8.7±7.8 |
| Stage I–II | 2.1±3.3 | 1.2±0.9 |
| Stage III–IV | 6.6±11.0 | 11.9±2.6b |
| Total mitosis | 14.5±22.7 | 35.8±30.7a |
| Stage I–II | 8.6±12.8 | 3.8±3.5 |
| Stage III–IV | 23.8±31.3 | 49.4±26.2b |
Data are presented as the mean ± standard deviation.
a
P<0.05 vs. SM by Student's t-test.
b
P<0.05 vs. stage I–II by Student's t-test. SM, skin melanoma; GM, gastrointestinal melanoma.